Bavituximab, known as TRWH-783, represents a exciting immunotherapy technique targeting phosphatidylserine (PS). PS is typically a cellular lipid present on cell membranes; however, it's frequently exposed on the https://dirstop.com/story28194062/bavituximab-a-novel-method-to-tumor-management